The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEQN.L Regulatory News (EQN)

  • There is currently no data for EQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Nov 2017 07:00

RNS Number : 0367X
Equiniti Group PLC
21 November 2017
 

 

21 November 2017

 

 

EQUINITI GROUP PLC - TRADING UPDATE

 

Equiniti Group plc ("Equiniti" or "the Group"), the specialist technology outsourcer providing non-discretionary payment and administration services, today issues the following trading update for the period 1 July 2017 to 21 November 2017.

 

TRADING

Trading in the period is in line with market expectations for full year 2017.

 

Our business is underpinned by the strength of our key client relationships, and we have continued to retain or extend all mandates, including those with AstraZeneca, Land Securities Group, Lloyds Banking Group, Smiths Group and Virgin Money Holdings (UK). This, coupled with corporate action activity and software sales, has accelerated momentum in the second half.

 

New client wins have been pleasing as we have continued to gain market share, with a record number of share registration clients choosing to move from our competitors. We are delighted to welcome Jardine Lloyd Thompson Group and Rentokil Initial as clients of the Group. We have also successfully migrated J Sainsbury as a new registration and share plan client during the period. Furthermore, we have grown our client base through the IPO market securing 75% of mandates from newly listed companies year to date. Our most recent wins include Bakkavor, Charter Court Financial Services, ContourGlobal, TI Fluid Systems, Ultimate Products and Velocity Composites. We have a strong pipeline of organic opportunities which will support future growth.

 

PROPOSED ACQUISITION OF WELLS FARGO SHAREOWNER SERVICES (WFSS)

On 12 July 2017, the Group announced the proposed acquisition and carve out of WFSS for a total cash consideration of £176m. The acquisition was approved at a General Meeting held on 28 September 2017 with 99.99% of shareholders voting in favour of the acquisition and a 97.43% uptake of the associated rights issue. The acquisition is proceeding as planned with completion expected in Q1 2018.

 

The joint programme team is making good progress in preparing for the integration of the business on completion of the transaction and the subsequent deployment of Equiniti's Sirius technology into the US market. Our plans for the business have been received with enthusiasm and support from existing major clients and transferring staff.

 

The Group's guidance on one-off transaction costs remains unchanged at c£17m and relates to advisory, debt and equity issuance costs. We also reaffirm previous guidance on transaction-related exceptional costs of c£20m by full year 2019, with c60% to be incurred during 2018 and transaction-related capital expenditure costs of c£22m by full year 2019, with c80% to be incurred during 2018.

 

IFRS 15 - REVENUE FROM CONTRACTS WITH CUSTOMERS

We have assessed the impact of IFRS 15 and at this stage we do not believe there will be a material impact on the Group's results. It is not our intention to early adopt IFRS 15 and our 2017 financial results will be prepared under current financial standards. However, the Group will provide additional quantitative disclosure on the impact of IFRS 15 on its income statement and balance sheet as part of the presentation of the 2017 financial results.

 

OUTLOOK

Our objective remains to deliver organic revenue growth supplemented by growth from capability enhancing acquisitions. The dependability of our revenues, the platform nature of our operations and progressive deleveraging will enable us to grow underlying profits and earnings ahead of revenue.

 

We continue to make progress against this strategy with multiple opportunities for future growth and are pleased to reaffirm our guidance for full year 2017.

 

FINANCIAL CALENDAR

7 March 2018 Full year results announcement

3 May 2018 AGM and trading update

27 July 2018 Interim results announcement

 

 

 

 

 

 

For further information please contact: 

 

Analyst/Investor enquiries:

Equiniti Group plc Guy Wakeley, Chief Executive +44 (0) 207 469 1811 

John Stier, Chief Financial Officer Frances Gibbons, Head of Investor Relations

 

Media enquiries:

Temple Bar Advisory Alex Child-Villiers + 44 (0) 7795 425580Will Barker + 44 (0) 7827 960151

Forward-looking statements

This announcement contains forward-looking statements regarding Equiniti. These forward-looking statements are based on current information and expectations, and are subject to risks and uncertainties, including market conditions and other factors outside of Equiniti's control. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. Equiniti undertakes no obligation to publicly update any forward-looking statement contained in this release, whether as a result of new information, future developments or otherwise, except as may be required by law. 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKKDPKBDBADB
Date   Source Headline
13th Dec 20218:00 amRNSRemoval- Equiniti Group plc
10th Dec 20213:30 pmRNSForm 8.3 - EQN LN
10th Dec 20213:20 pmRNSForm 8.3 - Equiniti Group Plc
10th Dec 20213:15 pmBUSForm 8.3 - Equiniti Group plc
10th Dec 20211:50 pmRNSForm 8.3 - Equiniti Group Plc
10th Dec 202111:56 amRNSForm 8.3 - Equiniti Group plc
10th Dec 202111:28 amRNSForm 8.5 (EPT/RI)
10th Dec 202111:21 amBUSForm 8.5 (EPT/NON-RI) - EQUINITI GROUP PLC
10th Dec 202110:51 amRNSForm 8.5 (EPT/RI)
10th Dec 202110:49 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 20219:27 amRNSForm 8.5 (EPT/RI)
10th Dec 20219:09 amRNSForm 8.3 - Equiniti Group Plc
10th Dec 20217:00 amRNSCompletion of Acquisition by Bidco
9th Dec 20213:20 pmRNSForm 8.3 - Equiniti Group Plc
9th Dec 20213:11 pmRNSHolding(s) in Company
9th Dec 20212:45 pmEQSForm 8.3 - The Vanguard Group, Inc.: Equiniti Group plc
9th Dec 20211:27 pmRNSForm 8.3 - Equinti Group Plc
9th Dec 202112:09 pmPRNForm 8.3 - Equiniti Group Plc
9th Dec 202111:51 amRNSForm 8.5 (EPT/RI)
9th Dec 202111:40 amRNSHolding(s) in Company
9th Dec 202111:40 amRNSForm 8.3 - Equiniti Group Plc
9th Dec 202111:02 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - EQUINITI GROUP PLC - Ordinary Shares
9th Dec 202110:49 amRNSForm 8.5 (EPT/RI)
9th Dec 202110:40 amRNSForm 8.5 (EPT/RI)
9th Dec 202110:40 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 202110:34 amBUSForm 8.5 (EPT/NON-RI) - EQUINITI GROUP PLC
8th Dec 20215:07 pmRNSRule 2.9 Announcement
8th Dec 20213:20 pmRNSForm 8.3 - Equiniti Group Plc
8th Dec 20213:05 pmRNSForm 8.3 - Equiniti Group plc
8th Dec 20212:05 pmRNSForm 8.3 - Equiniti Group Plc
8th Dec 20211:08 pmRNSScheme sanctioned by the Court
8th Dec 202111:39 amRNSForm 8.5 (EPT/RI)
8th Dec 202110:53 amRNSForm 8.5 (EPT/RI)
8th Dec 20219:58 amBUSForm 8.5 (EPT/NON-RI) - EQUINITI GROUP PLC
7th Dec 20213:30 pmRNSForm 8.3 - EQN LN
7th Dec 20213:20 pmRNSForm 8.3 - Equiniti Group Plc
7th Dec 20213:15 pmBUSForm 8.3 - Equiniti Group plc
7th Dec 20213:05 pmRNSForm 8.3 - EQUINITI GROUP PLC
7th Dec 202112:17 pmRNSForm 8.3 - Equiniti Group Plc
7th Dec 202112:11 pmBUSFORM 8.5 (EPT/NON-RI) - EQUINITI GROUP PLC
7th Dec 202111:53 amRNSForm 8.3 - Equiniti Group Plc
7th Dec 202111:31 amRNSForm 8.5 (EPT/RI)
7th Dec 202111:30 amRNSForm 8.5 (EPT/RI)
7th Dec 202111:27 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 202110:32 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - EQUINITI GROUP PLC - Ordinary Shares
7th Dec 20218:38 amRNSForm 8.5 (EPT/RI)
6th Dec 20216:11 pmRNSForm 8.5 (EPT/RI) - Amendment
6th Dec 20213:30 pmRNSForm 8.3 - EQN LN
6th Dec 20213:20 pmRNSForm 8.3 - Equiniti Group Plc
6th Dec 20212:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.